Overview

Harmonized AS/MQ Efficacy Study - Thailand

Status:
Completed
Trial end date:
2015-10-01
Target enrollment:
Participant gender:
Summary
The purposes of this study is to determine parasitological clearance rates by microscopy for the 72-hour period after first artesunate dose in subjects with uncomplicated P. falciparum malaria.
Phase:
Phase 4
Details
Lead Sponsor:
Armed Forces Research Institute of Medical Sciences, Thailand
Collaborators:
Global Emerging Infections Surveillance and Response System
Walter Reed Army Institute of Research (WRAIR)
Treatments:
Artemisinins
Artesunate
Mefloquine